Dark Forest Capital Management’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Other funds holding CORT
ISL
VPM
VCM
PA
Dark Forest Capital Management's CORT Position: Q1 2026 in Review
Dark Forest Capital Management opened a new position in Corcept Therapeutics (CORT) in Q1 2026: 21,449 shares worth $865K. The stake represents 0.08% of the portfolio and ranks #411 among its holdings. This is a return to the name: Dark Forest Capital Management previously reported a position in CORT as recently as Q2 2025.
Dark Forest Capital Management first reported a position in CORT in Q2 2021 and has held it in 7 quarters since. 351 funds tracked by Wall St. Rank hold CORT as of Q1 2026.
- Dark Forest Capital Management held 21,449 shares of Corcept Therapeutics worth $865K as of Q1 2026.
- Corcept Therapeutics was a new Dark Forest Capital Management position in Q1 2026.
- Corcept Therapeutics made up 0.08% of Dark Forest Capital Management's portfolio in Q1 2026, its #411 holding.
- Dark Forest Capital Management first reported a position in Corcept Therapeutics in Q2 2021 and has held it in 7 quarters since.
- 351 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.
Based on Dark Forest Capital Management's 13F filing for Q1 2026, filed 15 May 2026.